Position in ABBV
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$1,491,721
+$218,100 QoQ
Shares Held
5,928
+1.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.84%
of 13F equity value
Holder Rank
#2,179
of 4,153 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
0
PutValue
$45,698
PutShares
200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Key Client Fiduciary Advisors, LLC holds $6,120,333 across 7 Drug Manufacturers - General names. ABBV ranks #1 (24.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
5,928 | $1,491,721 | |
| 2 | LLY |
ELI LILLY & Co
|
1,195 | $1,433,318 | |
| 3 | MRK |
Merck & Co., Inc.
|
7,589 | $975,186 | |
| 4 | PFE |
Pfizer Inc
|
31,030 | $747,202 | |
| 5 | JNJ |
Johnson & Johnson
|
2,907 | $738,290 | |
| 6 | AMGN |
Amgen Inc
|
1,022 | $370,086 | |
| 7 | NVS |
Novartis AG
|
2,326 | $364,530 |
All Filings in ABBV
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,491,721 | 5,928 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $1,273,621 | 5,856 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $1,374,138 | 6,014 | Shares | Sole | 2026-01-28 | |
| 2025-12-31 | $45,698 | 200 | Put | Sole | 2026-01-28 | |
| 2025-09-30 | $3,144,776 | 13,582 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $2,521,276 | 13,583 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $2,843,814 | 13,573 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $2,425,960 | 13,652 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $2,693,232 | 13,638 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $2,355,312 | 13,732 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $2,638,264 | 14,488 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $2,378,944 | 15,351 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $2,461,725 | 16,515 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,214,691 | 16,438 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $2,649,048 | 16,622 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $2,654,282 | 16,424 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $363,038 | 2,705 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $410,928 | 2,683 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $444,667 | 2,743 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $373,162 | 2,756 | Shares | Sole | 2022-03-01 | |
| No filing history on record for this holder in this stock. | ||||||